- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ibrutinib
Total 346 results
-
National Cancer Institute (NCI)RecruitingChronic GVHDUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
Novartis PharmaceuticalsRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Large B-cell LymphomaJapan, Australia, Germany, Spain, Italy, United States, France, Austria
-
Dartmouth-Hitchcock Medical CenterCompleted
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Pharmacyclics LLC.TerminatedAcute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Pharmacyclics LLC.CompletedGraft Versus Host DiseaseUnited States
-
University Hospital, CaenNot yet recruitingAtrial Fibrillation | Hematological MalignancyFrance
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedB-cell Lymphoma | Marginal Zone LymphomaUnited States, Belgium, France, Germany, United Kingdom
-
Janssen Research & Development, LLCCompleted
-
Incyte CorporationCompleted
-
German CLL Study GroupJanssen-Cilag Ltd.CompletedChronic Lymphocytic LeukemiaGermany
-
University of Michigan Rogel Cancer CenterWithdrawnMantle Cell LymphomaUnited States
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Novartis PharmaceuticalsTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Peter MacCallum Cancer Centre, AustraliaNovartisActive, not recruitingMantle Cell Lymphoma RecurrentAustralia
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia
-
Rabin Medical CenterJanssen, LPRecruitingCentral Nervous System LymphomaIsrael
-
National Cancer Centre, SingaporeSamsung Medical Center; Singapore General HospitalTerminatedLymphoma, B-Cell, Marginal ZoneSingapore
-
Eugene NikitinUnknownAIHA - Warm Autoimmune Hemolytic AnemiaRussian Federation
-
Jason Robert GotlibNational Cancer Institute (NCI)TerminatedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingLeukemia, Lymphoblastic, ChronicItaly
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Terminated
-
Pharmacyclics LLC.CompletedDiffuse Large Cell B-lymphomaUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
Weill Medical College of Cornell UniversityMayo Clinic; Janssen Scientific Affairs, LLCTerminatedWaldenstrom Macroglobulinemia | Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory | Waldenstrom's Disease | Waldenström; Hypergammaglobulinemia | Waldenstrom's Macroglobulinemia of Lymph Nodes | Waldenstrom's Macroglobulinaemia, Without Mention of RemissionUnited States
-
Michael ChoiPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Italy, New Zealand, Poland, Spain
-
Pharmacyclics LLC.Active, not recruitingFollicular LymphomaUnited Kingdom, Portugal, Taiwan, Spain, Belgium, Netherlands, Israel, United States, Czechia, Italy, France, Hungary, Australia, Poland, Canada, Austria, Russian Federation, Greece, Turkey
-
Institute of Hematology & Blood Diseases HospitalRecruitingChronic Lymphocytic LeukemiaChina
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaUnited States, France, United Kingdom, Belgium, Spain, Israel, Puerto Rico, Poland, Russian Federation
-
Dana-Farber Cancer InstituteAbbVie; Pharmacyclics LLC.Active, not recruitingWaldenstrom Macroglobulinemia | MYD88 Gene MutationUnited States
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruiting
-
Incyte CorporationRecruitingB-Cell MalignanciesUnited States, Spain, Belgium, Japan, Poland, Italy, France, United Kingdom, Israel, Turkey, Norway, Korea, Republic of, Czechia, Sweden, Austria, Hungary, Denmark
-
Fondazione Italiana Linfomi - ETSJanssen-Cilag S.p.A.Recruiting
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
Oncternal Therapeutics, IncPharmacyclics LLC.WithdrawnImmune System Diseases | Lymphoma | Lymphoma, B-Cell | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1United States